|
1
|
Moses JW, Leon MB, Popma JJ, Fitzgerald
PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams
DO, Teirstein PS, et al: SIRIUS Investigators: Sirolimus-eluting
stents versus standard stents in patients with stenosis in a native
coronary artery. N Engl J Med. 349:1315–1323. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stone GW, Ellis SG, Cox DA, Hermiller J,
O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J,
et al: TAXUS-IV Investigators: A polymer-based, paclitaxel-eluting
stent in patients with coronary artery disease. N Engl J Med.
350:221–231. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Joner M, Finn AV, Farb A, Mont EK,
Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK and Virmani R:
Pathology of drug-eluting stents in humans: Delayed healing and
late thrombotic risk. J Am Coll Cardiol. 48:193–202. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Camenzind E, Steg PG and Wijns W: Stent
thrombosis late after implantation of first-generation drug-eluting
stents: A cause for concern. Circulation. 115:1440–1455; discussion
1455. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nakazawa G, Finn AV, Vorpahl M, Ladich ER,
Kolodgie FD and Virmani R: Coronary responses and differential
mechanisms of late stent thrombosis attributed to first-generation
sirolimus- and paclitaxel-eluting stents. J Am Coll Cardiol.
57:390–398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hausleiter J, Kastrati A, Wessely R, Dibra
A, Mehilli J, Schratzenstaller T, Graf I, Renke-Gluszko M, Behnisch
B, Dirschinger J, et al: Investigators of the Individualizable
Durg-Eluting Stent System to Abrogate Restenosis Project:
Prevention of restenosis by a novel drug-eluting stent system with
a dose-adjustable, polymer-free, on-site stent coating. Eur Heart
J. 26:1475–1481. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mehilli J, Kastrati A, Wessely R, Dibra A,
Hausleiter J, Jaschke B, Dirschinger J and Schömig A: Intracoronary
Stenting and Angiographic Restenosis-Test Equivalence Between 2
Drug-Eluting Stents (ISAR-TEST) Trial Investigators: Randomized
trial of a nonpolymer-based rapamycin-eluting stent versus a
polymer-based paclitaxel-eluting stent for the reduction of late
lumen loss. Circulation. 113:273–279. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ruef J, Störger H, Schwarz F and Haase J:
Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a
polymer-based paclitaxel-eluting stent (TAXUS) in real-world
coronary artery lesions. Catheter Cardiovasc Interv. 71:333–339.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen M, Zheng B, Wu Z, Peng HY, Wang XG,
Zhang B and Huo Y: Efficacy and safety of a novel nano-porous
polymer-free sirolimus-eluting stent in pigs. Chin Med J (Engl).
126:4731–4735. 2013.PubMed/NCBI
|
|
10
|
Gonzalo N, Serruys PW, Okamura T, van
Beusekom HM, Garcia-Garcia HM, van Soest G, van der Giessen W and
Regar E: Optical coherence tomography patterns of stent restenosis.
Am Heart J. 158:284–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Prati F, Regar E, Mintz GS, Arbustini E,
Di Mario C, Jang IK, Akasaka T, Costa M, Guagliumi G, Grube E, et
al: Expert's OCT Review Document: Expert review document on
methodology, terminology and clinical applications of optical
coherence tomography: Physical principles, methodology of image
acquisition and clinical application for assessment of coronary
arteries and atherosclerosis. Eur Heart J. 31:401–415. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murata A, Wallace-Bradley D, Tellez A,
Alviar C, Aboodi M, Sheehy A, Coleman L, Perkins L, Nakazawa G,
Mintz G, et al: Accuracy of optical coherence tomography in the
evaluation of neointimal coverage after stent implantation. JACC
Cardiovasc Imaging. 3:76–84. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fu Q, Suzuki N, Kozuma K, Miyagawa M,
Nomura T, Kawashima H, Shiratori Y, Ishikawa S, Kyono H and Isshiki
T: Quantitative optical coherence tomography analysis for late
in-stent restenotic lesions. Int Heart J. 56:13–17. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guagliumi G, Musumeci G, Sirbu V, Bezerra
HG, Suzuki N, Fiocca L, Matiashvili A, Lortkipanidze N, Trivisonno
A, Valsecchi O, et al: ODESSA Trial Investigators: Optical
coherence tomography assessment of in vivo vascular response after
implantation of overlapping bare-metal and drug-eluting stents.
JACC Cardiovasc Interv. 3:531–539. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Carter AJ, Aggarwal M, Kopia GA, Tio F,
Tsao PS, Kolata R, Yeung AC, Llanos G, Dooley J and Falotico R:
Long-term effects of polymer-based, slow-release, sirolimus-eluting
stents in a porcine coronary model. Cardiovasc Res. 63:617–624.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Virmani R, Kolodgie FD and Farb A:
Drug-eluting stents: Are they really safe? Am Heart Hosp J.
2:85–88. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stone GW, Moses JW, Ellis SG, Schofer J,
Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane
AJ, et al: Safety and efficacy of sirolimus- and paclitaxel-eluting
coronary stents. N Engl J Med. 356:998–1008. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pfisterer M, Brunner-La Rocca HP, Buser
PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F,
Osswald S and Kaiser C: BASKET-LATE Investigators: Late clinical
events after clopidogrel discontinuation may limit the benefit of
drug-eluting stents: An observational study of drug-eluting versus
bare-metal stents. J Am Coll Cardiol. 48:2584–2591. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nebeker JR, Virmani R, Bennett CL, Hoffman
JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW,
Whisenant BK, et al: Hypersensitivity cases associated with
drug-eluting coronary stents: A review of available cases from the
Research on Adverse Drug Events and Reports (RADAR) project. J Am
Coll Cardiol. 47:175–181. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Finn AV, Nakazawa G, Joner M, Kolodgie FD,
Mont EK, Gold HK and Virmani R: Vascular responses to drug eluting
stents: Importance of delayed healing. Arterioscler Thromb Vasc
Biol. 27:1500–1510. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shiratori Y, Cola C, Brugaletta S,
Alvarez-Contreras L, Martín-Yuste V, del Blanco BG, Ruiz-Salmeron
R, Díaz J, Pinar E, Martí V, García-Picart J and Sabaté M:
Randomized comparison between polymer-free versus polymer-based
paclitaxel-eluting stent: Two-year final clinical results. Circ
Cardiovasc Interv. 7:312–321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Y, Chen F, Muramatsu T, Xu B, Li Z,
Ge J, He Q, Yang Z, Li S, Wang L, et al: Nine-month angiographic
and two-year clinical follow-up of polymer-free sirolimus-eluting
stent versus durable-polymer sirolimus-eluting stent for coronary
artery disease: The Nano randomized trial. Chin Med J (Engl).
127:2153–2158. 2014.PubMed/NCBI
|
|
23
|
John MC, Wessely R, Kastrati A, Schömig A,
Joner M, Uchihashi M, Crimins J, Lajoie S, Kolodgie FD, Gold HK, et
al: Differential healing responses in polymer- and nonpolymer-based
sirolimus-eluting stents. JACC Cardiovasc Interv. 1:535–544. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen BX, Ma FY, Luo W, Ruan JH, Xie WL,
Zhao XZ, Sun SH, Guo XM, Wang F, Tian T and Chu XW: Neointimal
coverage of bare-metal and sirolimus-eluting stents evaluated with
optical coherence tomography. Heart. 94:566–570. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mandelias K, Tsantis S, Spiliopoulos S,
Katsakiori PF, Karnabatidis D, Nikiforidis GC and Kagadis GC:
Automatic quantitative analysis of in-stent restenosis using FD-OCT
in vivo intra-arterial imaging. Med Phys. 40:0631012013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bezerra HG, Costa MA, Guagliumi G, Rollins
AM and Simon DI: Intracoronary optical coherence tomography: A
comprehensive review clinical and research applications. JACC
Cardiovasc Interv. 2:1035–1046. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jia H, Liu H, Kong J, Hou J, Wu J, Zhang
M, Tian J, Liu H, Ma L, Hu S, et al: A novel polymer-free
paclitaxel-eluting stent with a nanoporous surface for rapid
endothelialization and inhibition of intimal hyperplasia:
Comparison with a polymer-based sirolimus-eluting stent and bare
metal stent in a porcine model. J Biomed Mater Res A. 98:629–637.
2011. View Article : Google Scholar : PubMed/NCBI
|
